Search

Search this Site

Holiday Eating Tips

December 9, 2013

It’s that time of the year again and the holiday decorations are going up. You are probably finalizing holiday plans and concentrating on shopping. It’s been a little over a week since Thanksgiving and you’re back to healthy eating, right? Remember that the holidays are just that, days. Holiday eating should be limited to a few days, not an entire season starting with Thanksgiving and ending mid January. Some or all of the progress you have made can be wiped out with 5-6 weeks of poor food choices. So what can you do to limit the damage? Try keeping these in mind:

  • Enjoying yourself doesn’t mean you have to overeat.
  • Schedule longer/harder workouts to coincide with holiday parties.
  • Try eating a low glycemic snack before you go to a party (like a low carb protein shake). You will be less likely to overeat.
  • Stock up on high protein/low carb breakfast items such as egg whites, cottage cheese, Greek yogurt, breakfast ham, etc. so you can get right back to healthy eating the morning after each party or event.

The longer you eat poorly, the harder it is to break the cycle. Bad eating, especially eating carbs, produces high insulin levels. Remember, insulin stores fat and blocks fat release. But it doesn’t take much to stop the high insulin levels. A high protein, low carb breakfast can leave you satisfied for 3-4 hours and break

Posted in Blog, Exercise/Nutrition News by rishman
November 14, 2013

Raymond Ishman, M.D. President, Cenegenics Philadelphia Director of Quality Assurance Cenegenics Elite Health A recent Veteran’s Administration study published in JAMA, the Journal of the American Medical Association, has received much media attention, raising fears regarding the use of testosterone replacement in aging men. The study had multiple flaws that limit its usefulness. Some of these flaws include:

  • This was an observational study. These types of studies do not show cause and effect.
  • Subjects in this study were relatively sick with advanced coronary disease.
  • Only 60% of study patients received one follow up blood study to see if their blood levels had improved.
  • Of those that had follow up testosterone levels, the average level was only 332 with the “normal range” being 250-1100. This could hardly be considered a therapeutic level.

The results of this study are contrary to the vast majority of studies supporting the benefits of testosterone replacement. Other studies using better methodology have concluded that:

  • “In men with low testosterone levels, testosterone treatment was associated with a decreased mortality compared with no testosterone treatment.” (Journal of Clinical Endocrinology and Metabolism, 2012)
  • “…testosterone concentrations are inversely related to mortality due to cardiovascu

Posted in Blog, Medical News by rishman
October 9, 2013

Raymond Ishman, M.D. President, Cenegenics Philadelphia Director of Quality Assurance Cenegenics Elite Health The media attention surrounding publication of the initial results of the Women’s Health Initiative (WHI) in 2002 led to much fear and confusion regarding the use of hormone therapy (HT) after menopause. This led to a dramatic reduction in prescriptions for HT in the United States and around the world. Although in 2002 it was stated that the results pertained to all women receiving HT, subsequent analyses of data from the Women’s Health Initiative (WHI) and others clearly showed that “younger women and those within 10 years of menopause had a very beneficial (overall) risk-to-benefit ratio.” A Study published in July of 2013 in the American Journal of Public Health estimates that “Over a 10-year span, starting in 2002, a minimum of 18,601 and as many as 91,610 postmenopausal women died prematurely because of the avoidance of estrogen therapy.” Their conclusion was that “Estrogen therapy in younger postmenopausal women is associated with a decisive reduction in all-cause mortality, but estrogen use in this population is low and continuing to fall.” According to a 2013 article in The Journal of Clinical Endocrinology and Metabolism, even data from WHI revealed:

  • A protective effect for coronary disease and a reduction in m

Posted in Blog, Medical News by rishman
July 31, 2013

Raymond Ishman, M.D. President, Cenegenics Philadelphia Director of Quality Assurance Cenegenics Elite Health

A handful of recent studies have linked omega-3 oils (or fish oil) to increased risk for prostate cancer, a claim that has obviously caused many of you a great deal of concern. In matters of health, it is important to look at a broad base of research and separate fact from fiction – which is what I’ll do in the following paragraphs. Let me start by stating that, despite these recent claims, I’ll continue taking my fish oil! We at Cenegenics continue to advocate the use of fish oils for their well-documented beneficial effects related to cardiovascular disease, cognitive function and arthritis. Contrary the recent study, the vast majority of medical research suggests that fish oil has no relationship to prostate cancer. Several studies even indicate it may prevent cancer. Here are a few examples:

  • The rate of prostate cancer in the US is roughly 10 times higher than in Japan, where fish oil consumption is 8 times higher.
  • The same team behind the most recent report linking prostate cancer to fish oil concluded in 2011 that the use of fish oil supplements was not associated with an increased risk for prostate cancer.
  • A 2010

Posted in Blog, Medical News by rishman
November 12, 2012

Raymond Ishman, M.D. President, Cenegenics Philadelphia Director of Quality Assurance Cenegenics Elite Health The Women’s Health Initiative (WHI) study was prematurely stopped in 2002 due to a reported increase in the incidence of breast cancer in women in the hormone replacement arm of the study. As a result, thousands of women have stopped, or been taken off their hormones unnecessarily. This has lead to needless confusion, suffering and fear, to the point of hysteria in some, regarding the use of hormone replacement therapy (HRT). Since then, many of the main findings of this study have been debunked, albeit with much less media attention. Multiple studies have challenged the conclusions of WHI. One such study was published in the British Medical Journal and released October 9, 2012. The data came from the Danish Osteoporosis Prevention Study where recently postmenopausal women, ages 45-58, were treated with or without HRT for 10 years. The original study was actually started in the early 1990s. Hormones were stopped at 10 years when the results of the Women’s Health Initiative (WHI) study were released in 2002, with follow up carried out until 2008. In the current report, the same data was analyzed for cardiovascular outcomes, cancer and overall mortality. In the Danish study, women who previously had a hysterectomy were given oral bioidentical estradiol. (Topical is no

Posted in Blog, Medical News by rishman